Naoko Iwata‐Yoshikawa

National Institute of Infectious Diseases — Japan

Medicine · Health Sciences

24h-index3.2kcitations62works6.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(40), COVID-19 Clinical Research Studies(17), Animal Virus Infections Studies(14), Viral gastroenteritis research and epidemiology(13), SARS-CoV-2 detection and testing(9)

Publications62 total

Structural and virological identification of neutralizing antibody footprint provides insights into therapeutic antibody design against SARS-CoV-2 variants
Communications Biology·2025· 1 citedOpen Access
Engineered DPP4 decoy confers broad-spectrum inhibition of MERS-CoV infection
Cell Biomaterials·2025· 3 citedOpen Access
A Mouse Model of Ovalbumin‐Induced Airway Allergy Exhibits Altered Localization of SARS‐CoV‐2‐Susceptible Cells in the Lungs, Which Reflects Omicron BA.5 Infection Dynamics, Viral Mutations, and Immunopathology
Microbiology and Immunology·2024Open Access
The comparison of pathogenicity among SARS-CoV-2 variants in domestic cats
Scientific Reports·2024· 8 citedOpen Access
Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults
NEJM Evidence·2024· 28 cited
Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice
Scientific Reports·2024· 1 citedOpen Access
Lethal severe fever with thrombocytopenia syndrome virus infection causes systemic germinal centre failure and massive T cell apoptosis in cats
Frontiers in Microbiology·2024· 3 citedOpen Access
2141. Preclinical Evaluation of PA-001: A Novel, Potential Macrocyclic Peptide-Based Treatment for COVID-19 Which Binds to the S2 Subunit of SARS-CoV-2 Spike Protein
Open Forum Infectious Diseases·2023· 1 citedOpen Access
High-throughput isolation of SARS-CoV-2 nucleocapsid antibodies for improved antigen detection
Biochemical and Biophysical Research Communications·2023· 2 citedOpen Access
Saturation time of exposure interval for cross-neutralization response to SARS-CoV-2: Implications for vaccine dose interval
iScience·2023· 6 citedOpen Access
Estimating serum cross-neutralizing responses to SARS-CoV-2 Omicron sub-lineages elicited by pre-Omicron or Omicron breakthrough infection with exposure interval compensation modeling
2023· 1 citedOpen Access
Specific COVID-19 risk behaviors and the preventive effect of personal protective equipment among healthcare workers in Japan
Global Health & Medicine·2023· 3 citedOpen Access
Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters
Journal of Virology·2023· 8 citedOpen Access
Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults
Vaccine·2022· 4 citedOpen Access
Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice
Scientific Reports·2022· 6 citedOpen Access
Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways
Nature Communications·2022· 106 citedOpen Access
Impact of reinfection with SARS-CoV-2 Omicron variants in previously infected hamsters
2022Open Access
Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology
Vaccine·2022· 21 citedOpen Access
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys
Vaccine·2022· 20 citedOpen Access
Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology
2022· 2 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Noriyo Nagata(43), Tadaki Suzuki(33), Hideki Hasegawa(28), Shuetsu Fukushi(16), Nozomi Shiwa-Sudo(12), Yasushi Ami(11), Ken Maeda(11), Akira Ainai(11), Yuko Sato(9), Shigeru Morikawa(9), Masayuki Saijo(8), Eun‐Sil Park(8), Masayuki Shimojima(7), Yoshimasa Takahashi(7), Osamu Kotani(7), Hiroyuki Shimizu(7), Yusuke Sakai(7), Tomoki Yoshikawa(6), Shun Iida(6), Souichi Yamada(6)